Effects of PDE5 Inhibitors and sGC Stimulators in a Rat Model of Artificial Ureteral CalculosisReport as inadecuate




Effects of PDE5 Inhibitors and sGC Stimulators in a Rat Model of Artificial Ureteral Calculosis - Download this document for free, or read online. Document in PDF available to download.

Urinary colics from calculosis are frequent and intense forms of pain whose current pharmacological treatment remains unsatisfactory. New and more effective drugs are needed to control symptoms and improve stone expulsion. Recent evidence suggested that the Nitric Oxide NO - cyclic guanosine monophosphate cGMP - phosphodiesterase type 5 PDE5 system may contribute to ureteral motility influencing stone expulsion. We investigated if PDE5 inhibitors and sGC stimulators influence ureteral contractility, pain behaviour and stone expulsion in a rat model of ureteral calculosis. We investigated: athe sex-specific PDE5 distribution in the rat ureter; bthe functional in vitro effects of vardenafil and sildenafil PDE5 inhibitors and BAY41-2272 sGC stimulator on induced ureteral contractility in rats and cthe in vivo effectiveness of vardenafil and BAY41-2272, alone and combined with ketoprofen, vs hyoscine-N-butylbromide alone or combined with ketoprofen, on behavioural pain indicators and stone expulsion in rats with artificial calculosis in one ureter. PDE5 was abundantly expressed in male and female rats’ ureter. In vitro, both vardenafil and BAY41-2272 significantly relaxed pre-contracted ureteral strips. In vivo, all compounds significantly reduced number and global duration of -ureteral crises- and post-stone lumbar muscle hyperalgesia in calculosis rats. The highest level of reduction of the pain behaviour was observed with BAY41-2272 among all spasmolytics administered alone, and with the combination of ketoprofen with BAY41-2272. The percentage of stone expulsion was maximal in the ketoprofen+BAY41-2272 group. The NO-cGMP-PDE5 pathway is involved in the regulation of ureteral contractility and pain behaviour in urinary calculosis. PDE5 inhibitors and sGC stimulators could become a potent new option for treatment of urinary colic pain.



Author: Peter Sandner, Hanna Tinel, Giannapia Affaitati, Raffaele Costantini, Maria Adele Giamberardino

Source: http://plos.srce.hr/



DOWNLOAD PDF




Related documents